SG
Stefan Galluppi
Chief Innovation Officer

Stefan Galluppi insider trades: LifeMD (LFMD) stock buys and sales

Chief Innovation Officer, LifeMD Last trade Jun 13, 2025 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2019
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stefan reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 13, 2025LFMD↓ Sell$1.1M
Sep 11, 2024LFMD↑ Buy$15K
May 23, 2023LFMD↑ Buy$22K
Nov 17, 2021LFMD↑ Buy$9K
Nov 15, 2021LFMD↑ Buy$10K
May 19, 2021LFMD↑ Buy$39K
Sep 23, 2020CVLB↓ Sell$401K
Apr 25, 2019CVLB↑ Buy$750

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LFMD insiders

Open-market trades in the last 12 months

About Stefan Galluppi's insider trades

Stefan Galluppi is Chief Innovation Officer at LifeMD (LFMD). Since Apr 25, 2019, Stefan has reported 6 open-market purchases worth $96K and 2 sales worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LFMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.